Similar strategies have also been applied to discover major histocompatibility complex-bound peptides (MHC-peptides) from non-canonical sources (22–25) that contribute to an under-appreciated quantity of known targetable epitopes in cancer immunotherapy. Here, HLA-C is linked to cancer.